277 related articles for article (PubMed ID: 24438336)
41. [Risk assessment of vertical transmission of Toxoplasma infections].
Vimercati A; Greco P; D'Apolito A; Angelici MC; Possenti A; Carbonara S; Selvaggi L
Acta Biomed Ateneo Parmense; 2000; 71 Suppl 1():537-40. PubMed ID: 11424802
[TBL] [Abstract][Full Text] [Related]
42. Follow-up of Toxoplasmosis during Pregnancy: Ten-Year Experience in a University Hospital in Southern Brazil.
Diesel AA; Zachia SA; Müller ALL; Perez AV; Uberti FAF; Magalhães JAA
Rev Bras Ginecol Obstet; 2019 Sep; 41(9):539-547. PubMed ID: 31546277
[TBL] [Abstract][Full Text] [Related]
43. [Monitoring and treatment of toxoplasmosis in the pregnant woman, fetus and newborn].
Garin JP; Mojon M; Piens MA; Chevalier-Nuttall I
Pediatrie; 1989; 44(9):705-12. PubMed ID: 2695891
[TBL] [Abstract][Full Text] [Related]
44. Treatment of congenital toxoplasmosis during pregnancy.
Wilson CB
J Pediatr; 1990 Jun; 116(6):1003-5. PubMed ID: 2348287
[No Abstract] [Full Text] [Related]
45. [Value of prevention of congenital toxoplasmosis].
Douche C; Benabdesselam A; Mokhtari F; Le Mer Y
J Fr Ophtalmol; 1996; 19(5):330-4. PubMed ID: 8762899
[TBL] [Abstract][Full Text] [Related]
46. Congenital toxoplasmosis.
Olliaro P
Clin Evid; 2002 Jun; (7):623-6. PubMed ID: 12230689
[No Abstract] [Full Text] [Related]
47. Management of Toxoplasma gondii infection during pregnancy.
Montoya JG; Remington JS
Clin Infect Dis; 2008 Aug; 47(4):554-66. PubMed ID: 18624630
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of toxoplasmosis in pregnant women and vertical transmission of Toxoplasma gondii in patients from basic units of health from Gurupi, Tocantins, Brazil, from 2012 to 2014.
Gontijo da Silva M; Clare Vinaud M; de Castro AM
PLoS One; 2015; 10(11):e0141700. PubMed ID: 26558622
[TBL] [Abstract][Full Text] [Related]
49. [Use of the ISAGA method in detection of specific IgM, IgA, IgE antibodies in acquired and congenital toxoplasmosis].
Paul M
Wiad Parazytol; 1997; 43(1):39-51. PubMed ID: 9289926
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of serological prenatal screening to detect Toxoplasma gondii infections in Austria.
Prusa AR; Kasper DC; Olischar M; Husslein P; Pollak A; Hayde M
Neonatology; 2013; 103(1):27-34. PubMed ID: 23018152
[TBL] [Abstract][Full Text] [Related]
51. Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodies.
Meroni V; Genco F; Tinelli C; Lanzarini P; Bollani L; Stronati M; Petersen E
Clin Vaccine Immunol; 2009 Oct; 16(10):1517-20. PubMed ID: 19692628
[TBL] [Abstract][Full Text] [Related]
52. [Effect of antenatal spiramycin treatment on the frequency of retinochoroiditis due to congenital toxoplasmosis in a Colombian cohort].
Zuluaga LM; Hernández JC; Castaño CF; Donado JH
Biomedica; 2017 Apr; 37(0):86-91. PubMed ID: 28527270
[TBL] [Abstract][Full Text] [Related]
53. Congenital toxoplasmosis after a preconceptional or periconceptional maternal infection.
Robert-Gangneux F; Yera H; D'Herve D; Guiguen C
Pediatr Infect Dis J; 2009 Jul; 28(7):660-1. PubMed ID: 19561432
[TBL] [Abstract][Full Text] [Related]
54. [Diagnosis and therapy of toxoplasmosis infections in pregnancy at the Rostock University Gynecologic Clinic 1986-1994].
Briese V; Rogmann K; Müller H; Plesse R
Zentralbl Gynakol; 1995; 117(11):578-84. PubMed ID: 8533491
[TBL] [Abstract][Full Text] [Related]
55. [Significance of diagnostics and treatment in preventing congenital infections with Toxoplasma gondii (Tg), cytomegalovirus (CMV) and parvowirus B19 (PVB19)].
Szenborn L
Przegl Lek; 2010; 67(1):54-7. PubMed ID: 20509575
[TBL] [Abstract][Full Text] [Related]
56. Diagnosis of congenital toxoplasmosis in the neonatal period: A multicenter evaluation.
Naessens A; Jenum PA; Pollak A; Decoster A; Lappalainen M; Villena I; Lebech M; Stray-Pedersen B; Hayde M; Pinon JM; Petersen E; Foulon W
J Pediatr; 1999 Dec; 135(6):714-9. PubMed ID: 10586174
[TBL] [Abstract][Full Text] [Related]
57. [Congenital toxoplasmosis. Remarks apropos of serologic surveillance in 15,000 pregnant women].
Lapierre J; Tourte-Schaefer C; Heyer F; Nessmann C; Timbart MF; Beaujouan L
Sem Hop; 1983 Nov; 59(40):2741-5. PubMed ID: 6316531
[TBL] [Abstract][Full Text] [Related]
58. Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection.
Couvreur J; Desmonts G; Thulliez P
J Antimicrob Chemother; 1988 Jul; 22 Suppl B():193-200. PubMed ID: 3182443
[TBL] [Abstract][Full Text] [Related]
59. [Congenital toxoplasmosis retinochoroiditis after primary infection of the mother in pregnancy].
Kuchar A; Hayde M; Steinkogler FJ
Ophthalmologe; 1996 Apr; 93(2):190-3. PubMed ID: 8652987
[TBL] [Abstract][Full Text] [Related]
60. [Toxoplasmosis and pregnancy. Multicenter study of 16,362 pregnant women in Barcelona].
Muñoz Batet C; Guardià Llobet C; Juncosa Morros T; Viñas Domenech L; Sierra Soler M; Sanfeliu Sala I; Bosch Mestres J; Dopico Ponte E; Lite Lite J; Matas Andreu L; Juste Sánchez C; Barranco Romeu M
Med Clin (Barc); 2004 Jun; 123(1):12-6. PubMed ID: 15207221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
